Bio-Works Technologies AB (publ) (FRA:1BD)

Market Cap	38.89M +305.5%
Revenue (ttm)	7.58M +153.6%
Net Income	-236.40K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.3690
Previous Close	0.3710
Day's Range	0.3690 - 0.3690
52-Week Range	0.1295 - 0.4140
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 13, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2006
• Employees: 31
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1BD

Financial Performance

In 2025, Bio-Works Technologies AB's revenue was 62.50 million, an increase of 105.02% compared to the previous year's 30.49 million. Losses were -15.25 million, -59.19% less than in 2024.

Financial numbers in SEK